Global pharmaceutical company
Enterprise BI platform and analytics portfolio
25,000Global users on the platform
40%+Increase in platform adoption
$500K+Productivity gains, 900+ hours a month removed
The constraint was adoption, not capability. Twenty five thousand users came from standardising governed self service, not from building more.
The situation
A global BI platform serving a research organisation, with a large analytics portfolio and adoption that did not match the investment.
What I did
- Owned the enterprise BI and visualisation platform and a $12M+ analytics portfolio across drug development globally.
- Built the drug development data, analytics and AI function inside the corporate centre of excellence, including talent development and succession.
- Delivered 18+ data and analytics products and standardised governed self service across all regions.
- Drove automation led delivery improvement rather than adding headcount.
What it produced
40%+Increase in platform adoption
$500K+Productivity gains, 900+ hours a month removed
Not sure where your money is going? Seven questions, three minutes, no email.
Take the 7D Index Request a 45 minute call